Oesch F, Wolf C R
Institute of Toxicology, University of Mainz, Federal Republic of Germany.
Biochem Pharmacol. 1989 Jan 15;38(2):353-9. doi: 10.1016/0006-2952(89)90049-x.
Hexachloro-1,3-butadiene (HCBD) is a substrate for the hepatic microsomal glutathione transferases and is metabolised at higher rates by these enzymes than their cytosolic counterparts. Conjugation reactions catalysed by the microsomal and cytosolic transferases have been studied and characterized using this substrate and 1-chloro-2,4-dinitrobenzene (CDNB). In rat liver microsomes the Km values for HCBD and CDNB were 0.91 and 0.012 mM and in cytosol 0.51 and 0.10 mM respectively. Vmax values for HCBD were 1.39 and 0.35 nmol conjugate formed/min/mg protein for microsomes and cytosol respectively. In microsomal systems HCBD was a potent competitive inhibitor of the metabolism of CDNB with a Ki value of approximately 10 microM. However, CDNB did not inhibit HCBD metabolism significantly. These data suggest that more than one microsomal enzyme is involved in HCBD metabolism. The microsomal membrane could be solubilized without significant inhibition of HCBD activity; however, some detergents did inhibit the conjugation reaction. Activity was also lost on treatment of microsomal membranes with trypsin indicating the enzyme is localized on the cytoplasmic surface of the endoplasmic reticulum. Pretreatment of the rats with Aroclor 1254, 3-methylcholanthrene or phenobarbital did not change the microsomal conjugation of HCBD or CDNB with glutathione. Of seven species investigated, a human liver sample showed the highest ratio of microsomal to cytosolic glutathione transferase activity for HCBD (in microsomes 40-fold higher specific activity than in cytosol). Glutathione conjugation appears to play a critical role in the toxicity and carcinogenicity of some halogenated hydrocarbons. These data substantiate the potentially important role for the microsomal glutathione transferase in catalysing these reactions.
六氯-1,3-丁二烯(HCBD)是肝脏微粒体谷胱甘肽转移酶的底物,这些酶对其代谢速率高于胞质中的对应酶。已使用该底物和1-氯-2,4-二硝基苯(CDNB)对微粒体和胞质转移酶催化的结合反应进行了研究和表征。在大鼠肝脏微粒体中,HCBD和CDNB的Km值分别为0.91和0.012 mM,在胞质溶胶中分别为0.51和0.10 mM。HCBD的Vmax值分别为微粒体和胞质溶胶中每分钟每毫克蛋白质形成1.39和0.35 nmol共轭物。在微粒体系统中,HCBD是CDNB代谢的有效竞争性抑制剂,Ki值约为10 microM。然而,CDNB对HCBD代谢没有明显抑制作用。这些数据表明,不止一种微粒体酶参与了HCBD代谢。微粒体膜可以溶解而不会对HCBD活性产生明显抑制;然而,一些去污剂确实会抑制结合反应。用胰蛋白酶处理微粒体膜后活性也会丧失,这表明该酶定位于内质网的细胞质表面。用多氯联苯混合物1254、3-甲基胆蒽或苯巴比妥预处理大鼠,并未改变HCBD或CDNB与谷胱甘肽的微粒体结合。在所研究的七个物种中,一份人类肝脏样本显示HCBD的微粒体与胞质谷胱甘肽转移酶活性之比最高(微粒体中的比活性比胞质溶胶中高40倍)。谷胱甘肽结合似乎在某些卤代烃的毒性和致癌性中起关键作用。这些数据证实了微粒体谷胱甘肽转移酶在催化这些反应中可能具有的重要作用。